Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-07-20

Clinical Trial Update: Use of Phenylephrine for Assessment of Mitral Regurgitation Severity [Phase 1, Phase 2]

View source ↗

Summary

This clinical trial update discusses using phenylephrine to assess the severity of mitral regurgitation in Phase 1/2 studies.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Phenylephrine (phenylephrine)

Snippet

Sponsor: Montefiore Medical Center | Conditions: Mitral Regurgitation | Phase 1, Phase 2 | Status: RECRUITING